Sweet's syndrome revisited: a review of disease concepts
Identifieur interne : 001198 ( Istex/Corpus ); précédent : 001197; suivant : 001199Sweet's syndrome revisited: a review of disease concepts
Auteurs : Philip R. Cohen ; Razelle KurzrockSource :
- International Journal of Dermatology [ 0011-9059 ] ; 2003-10.
Abstract
Sweet's syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by a constellation of symptoms and findings: fever, neutrophilia, erythematous and tender skin lesions that typically show an upper dermal infiltrate of mature neutrophils, and prompt improvement of both symptoms and lesions after the initiation of treatment with systemic corticosteroids. Hundreds of patients with this dermatosis have been reported. The manifestations of Sweet's syndrome in these individuals have not only confirmed those originally described by Dr Robert Douglas Sweet in 1964, but have also introduced new features that have expanded the clinical and pathologic concepts of this condition. The history, clinical characteristics, laboratory findings, associated diseases, pathology, and treatment options of Sweet's syndrome are reviewed. The evolving and new concepts of this dermatosis that are discussed include: (i) Sweet's syndrome occurring in the clinical setting of a disease‐related malignancy, or medication, or both; (ii) detection of additional sites of extracutaneous Sweet's syndrome manifestations; (iii) discovery of additional Sweet's syndrome‐associated diseases; (iv) variability of the composition and/or location of the cutaneous inflammatory infiltrate in Sweet's syndrome lesions; and (v) additional efficacious treatments for Sweet's syndrome.
Url:
DOI: 10.1046/j.1365-4362.2003.01891.x
Links to Exploration step
ISTEX:27456AA1A506415D425CC0EC1B7C644278247D02Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sweet's syndrome revisited: a review of disease concepts</title><author><name sortKey="Cohen, Philip R" sort="Cohen, Philip R" uniqKey="Cohen P" first="Philip R." last="Cohen">Philip R. Cohen</name><affiliation><mods:affiliation>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: mitehead@aol.com</mods:affiliation></affiliation></author><author><name sortKey="Kurzrock, Razelle" sort="Kurzrock, Razelle" uniqKey="Kurzrock R" first="Razelle" last="Kurzrock">Razelle Kurzrock</name><affiliation><mods:affiliation>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:27456AA1A506415D425CC0EC1B7C644278247D02</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1046/j.1365-4362.2003.01891.x</idno><idno type="url">https://api.istex.fr/document/27456AA1A506415D425CC0EC1B7C644278247D02/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001198</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001198</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Sweet's syndrome revisited: a review of disease concepts</title><author><name sortKey="Cohen, Philip R" sort="Cohen, Philip R" uniqKey="Cohen P" first="Philip R." last="Cohen">Philip R. Cohen</name><affiliation><mods:affiliation>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: mitehead@aol.com</mods:affiliation></affiliation></author><author><name sortKey="Kurzrock, Razelle" sort="Kurzrock, Razelle" uniqKey="Kurzrock R" first="Razelle" last="Kurzrock">Razelle Kurzrock</name><affiliation><mods:affiliation>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">International Journal of Dermatology</title><title level="j" type="alt">INTERNATIONAL JOURNAL OF DERMATOLOGY</title><idno type="ISSN">0011-9059</idno><idno type="eISSN">1365-4632</idno><imprint><biblScope unit="vol">42</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="761">761</biblScope><biblScope unit="page" to="778">778</biblScope><biblScope unit="page-count">18</biblScope><publisher>Blackwell Publishing Ltd.</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2003-10">2003-10</date></imprint><idno type="ISSN">0011-9059</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0011-9059</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Sweet's syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by a constellation of symptoms and findings: fever, neutrophilia, erythematous and tender skin lesions that typically show an upper dermal infiltrate of mature neutrophils, and prompt improvement of both symptoms and lesions after the initiation of treatment with systemic corticosteroids. Hundreds of patients with this dermatosis have been reported. The manifestations of Sweet's syndrome in these individuals have not only confirmed those originally described by Dr Robert Douglas Sweet in 1964, but have also introduced new features that have expanded the clinical and pathologic concepts of this condition. The history, clinical characteristics, laboratory findings, associated diseases, pathology, and treatment options of Sweet's syndrome are reviewed. The evolving and new concepts of this dermatosis that are discussed include: (i) Sweet's syndrome occurring in the clinical setting of a disease‐related malignancy, or medication, or both; (ii) detection of additional sites of extracutaneous Sweet's syndrome manifestations; (iii) discovery of additional Sweet's syndrome‐associated diseases; (iv) variability of the composition and/or location of the cutaneous inflammatory infiltrate in Sweet's syndrome lesions; and (v) additional efficacious treatments for Sweet's syndrome.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>dermatol</json:string><json:string>neutrophilic</json:string><json:string>dermatosis</json:string><json:string>syndrome</json:string><json:string>dermatology</json:string><json:string>neutrophilic dermatosis</json:string><json:string>acad</json:string><json:string>acad dermatol</json:string><json:string>kurzrock</json:string><json:string>cutis</json:string><json:string>cutaneous</json:string><json:string>clin</json:string><json:string>neutrophil</json:string><json:string>vasculitis</json:string><json:string>neutrophilic dermatosis syndrome</json:string><json:string>pustular</json:string><json:string>international society</json:string><json:string>erythema</json:string><json:string>lesion</json:string><json:string>subcutaneous</json:string><json:string>panniculitis</json:string><json:string>colchicine</json:string><json:string>corticosteroid</json:string><json:string>arch dermatol</json:string><json:string>sweet syndrome</json:string><json:string>paraneoplastic</json:string><json:string>international journal</json:string><json:string>potassium iodide</json:string><json:string>syndrome lesions</json:string><json:string>hematologic</json:string><json:string>pediatr</json:string><json:string>granulocyte</json:string><json:string>dermis</json:string><json:string>extracutaneous</json:string><json:string>dorsal</json:string><json:string>leukemia cutis</json:string><json:string>nodosum</json:string><json:string>nodule</json:string><json:string>dorsal hands</json:string><json:string>skin lesions</json:string><json:string>venereol</json:string><json:string>review syndrome</json:string><json:string>abnormality</json:string><json:string>bowel</json:string><json:string>erythema nodosum</json:string><json:string>pustular vasculitis</json:string><json:string>inflammatory</json:string><json:string>cohen</json:string><json:string>indomethacin</json:string><json:string>dermatology cohen</json:string><json:string>acta</json:string><json:string>myelodysplastic</json:string><json:string>rheumatoid</json:string><json:string>monotherapy</json:string><json:string>idiopathic</json:string><json:string>leukemia</json:string><json:string>syndrome patients</json:string><json:string>lupus</json:string><json:string>leukocytoclastic</json:string><json:string>granulocyte factor</json:string><json:string>myelodysplastic syndrome</json:string><json:string>erythematous</json:string><json:string>immunodeficiency</json:string><json:string>dermatologica</json:string><json:string>australas</json:string><json:string>subcutaneous syndrome</json:string><json:string>malignancy</json:string><json:string>dermatology syndrome</json:string><json:string>rheumatoid arthritis</json:string><json:string>mature neutrophils</json:string><json:string>myeloid</json:string><json:string>pathologic features</json:string><json:string>solid tumors</json:string><json:string>syndrome skin lesions</json:string><json:string>daily dose</json:string><json:string>case report</json:string><json:string>cutaneous paraneoplastic syndromes</json:string><json:string>inflammatory bowel disease</json:string><json:string>pathologic</json:string><json:string>myelogenous leukemia</json:string><json:string>adipose tissue</json:string><json:string>case reports</json:string><json:string>leukemic cells</json:string><json:string>neutrophilic dermatoses</json:string><json:string>diagnostic criteria</json:string><json:string>cutaneous manifestations</json:string><json:string>recurrent syndrome</json:string><json:string>combination therapy</json:string><json:string>hematologic malignancies</json:string><json:string>acta derm venereol</json:string><json:string>pathologic changes</json:string><json:string>gastrointestinal tract</json:string><json:string>idiopathic syndrome</json:string><json:string>successful management</json:string><json:string>successful treatment</json:string><json:string>arch intern</json:string><json:string>paraneoplastic syndrome</json:string><json:string>bronchiolitis obliterans</json:string><json:string>mayo clin proc</json:string><json:string>concurrent syndrome</json:string><json:string>current report</json:string><json:string>pyoderma gangrenosum</json:string><json:string>pediatr dermatol</json:string><json:string>clin dermatol</json:string><json:string>chronic granulomatous disease</json:string><json:string>extracutaneous manifestations</json:string><json:string>leukocytoclastic vasculitis</json:string><json:string>ulcerative colitis</json:string><json:string>pustular eruption</json:string><json:string>acute neutrophilic dermatosis</json:string><json:string>kurzrock syndrome</json:string><json:string>upper dermis</json:string><json:string>cutaneous lesions</json:string><json:string>pustular panniculitis</json:string><json:string>systemic</json:string></teeft></keywords><author><json:item><name>Philip R. Cohen MD</name><affiliations><json:string>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas</json:string><json:string>E-mail: mitehead@aol.com</json:string></affiliations></json:item><json:item><name>Razelle Kurzrock MD</name><affiliations><json:string>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas</json:string></affiliations></json:item></author><articleId><json:string>IJD1891</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>reviewArticle</json:string></originalGenre><abstract>Sweet's syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by a constellation of symptoms and findings: fever, neutrophilia, erythematous and tender skin lesions that typically show an upper dermal infiltrate of mature neutrophils, and prompt improvement of both symptoms and lesions after the initiation of treatment with systemic corticosteroids. Hundreds of patients with this dermatosis have been reported. The manifestations of Sweet's syndrome in these individuals have not only confirmed those originally described by Dr Robert Douglas Sweet in 1964, but have also introduced new features that have expanded the clinical and pathologic concepts of this condition. The history, clinical characteristics, laboratory findings, associated diseases, pathology, and treatment options of Sweet's syndrome are reviewed. The evolving and new concepts of this dermatosis that are discussed include: (i) Sweet's syndrome occurring in the clinical setting of a disease‐related malignancy, or medication, or both; (ii) detection of additional sites of extracutaneous Sweet's syndrome manifestations; (iii) discovery of additional Sweet's syndrome‐associated diseases; (iv) variability of the composition and/or location of the cutaneous inflammatory infiltrate in Sweet's syndrome lesions; and (v) additional efficacious treatments for Sweet's syndrome.</abstract><qualityIndicators><score>7.232</score><pdfVersion>1.3</pdfVersion><pdfPageSize>595 x 782 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1382</abstractCharCount><pdfWordCount>10741</pdfWordCount><pdfCharCount>77648</pdfCharCount><pdfPageCount>18</pdfPageCount><abstractWordCount>186</abstractWordCount></qualityIndicators><title>Sweet's syndrome revisited: a review of disease concepts</title><genre><json:string>review-article</json:string></genre><host><title>International Journal of Dermatology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1365-4632</json:string></doi><issn><json:string>0011-9059</json:string></issn><eissn><json:string>1365-4632</json:string></eissn><publisherId><json:string>IJD</json:string></publisherId><volume>42</volume><issue>10</issue><pages><first>761</first><last>778</last><total>18</total></pages><genre><json:string>journal</json:string></genre></host><categories><wos><json:string>science</json:string><json:string>dermatology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>dermatology & venereal diseases</json:string></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string></inist></categories><publicationDate>2003</publicationDate><copyrightDate>2003</copyrightDate><doi><json:string>10.1046/j.1365-4362.2003.01891.x</json:string></doi><id>27456AA1A506415D425CC0EC1B7C644278247D02</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/27456AA1A506415D425CC0EC1B7C644278247D02/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/27456AA1A506415D425CC0EC1B7C644278247D02/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/27456AA1A506415D425CC0EC1B7C644278247D02/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Sweet's syndrome revisited: a review of disease concepts</title></titleStmt><publicationStmt><publisher>Blackwell Publishing Ltd.</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2003-10"></date></publicationStmt><notesStmt><note type="content-type" subtype="review-article" source="reviewArticle" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main">Sweet's syndrome revisited: a review of disease concepts</title><title level="a" type="short">Sweet"s syndrome revisited</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">Philip R.</forename><surname>Cohen</surname><roleName type="degree">MD</roleName></persName><affiliation>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas<address><country key="US"></country></address></affiliation><affiliation>Philip R. Cohen, MD, 805 Anderson Street, Bellaire, TX 77401‐2806 USA E‐mail: mitehead@aol.com</affiliation></author><author xml:id="author-0001"><persName><forename type="first">Razelle</forename><surname>Kurzrock</surname><roleName type="degree">MD</roleName></persName><affiliation>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas<address><country key="US"></country></address></affiliation></author><idno type="istex">27456AA1A506415D425CC0EC1B7C644278247D02</idno><idno type="DOI">10.1046/j.1365-4362.2003.01891.x</idno><idno type="unit">IJD1891</idno><idno type="toTypesetVersion">file:IJD.IJD1891.pdf</idno></analytic><monogr><title level="j" type="main">International Journal of Dermatology</title><title level="j" type="alt">INTERNATIONAL JOURNAL OF DERMATOLOGY</title><idno type="pISSN">0011-9059</idno><idno type="eISSN">1365-4632</idno><idno type="book-DOI">10.1111/(ISSN)1365-4632</idno><idno type="book-part-DOI">10.1111/ijd.2003.42.issue-10</idno><idno type="product">IJD</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">42</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="761">761</biblScope><biblScope unit="page" to="778">778</biblScope><biblScope unit="page-count">18</biblScope><publisher>Blackwell Publishing Ltd.</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2003-10"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head><p>Sweet's syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by a constellation of symptoms and findings: fever, neutrophilia, erythematous and tender skin lesions that typically show an upper dermal infiltrate of mature neutrophils, and prompt improvement of both symptoms and lesions after the initiation of treatment with systemic corticosteroids. Hundreds of patients with this dermatosis have been reported. The manifestations of Sweet's syndrome in these individuals have not only confirmed those originally described by Dr Robert Douglas Sweet in 1964, but have also introduced new features that have expanded the clinical and pathologic concepts of this condition. The history, clinical characteristics, laboratory findings, associated diseases, pathology, and treatment options of Sweet's syndrome are reviewed. The evolving and new concepts of this dermatosis that are discussed include: (i) Sweet's syndrome occurring in the clinical setting of a disease‐related malignancy, or medication, or both; (ii) detection of additional sites of extracutaneous Sweet's syndrome manifestations; (iii) discovery of additional Sweet's syndrome‐associated diseases; (iv) variability of the composition and/or location of the cutaneous inflammatory infiltrate in Sweet's syndrome lesions; and (v) additional efficacious treatments for Sweet's syndrome.</p></abstract><textClass><classCode scheme="tocHeading1">Review</classCode></textClass><langUsage><language ident="EN"></language></langUsage></profileDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/27456AA1A506415D425CC0EC1B7C644278247D02/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd.</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1365-4632</doi><issn type="print">0011-9059</issn><issn type="electronic">1365-4632</issn><idGroup><id type="product" value="IJD"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="INTERNATIONAL JOURNAL OF DERMATOLOGY">International Journal of Dermatology</title></titleGroup></publicationMeta><publicationMeta level="part" position="10010"><doi origin="wiley">10.1111/ijd.2003.42.issue-10</doi><numberingGroup><numbering type="journalVolume" number="42">42</numbering><numbering type="journalIssue" number="10">10</numbering></numberingGroup><coverDate startDate="2003-10">October 2003</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="1" status="forIssue"><doi origin="wiley">10.1046/j.1365-4362.2003.01891.x</doi><idGroup><id type="unit" value="IJD1891"></id></idGroup><countGroup><count type="pageTotal" number="18"></count></countGroup><titleGroup><title type="tocHeading1">Review</title></titleGroup><eventGroup><event type="firstOnline" date="2003-10-02"></event><event type="publishedOnlineFinalForm" date="2003-10-02"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-04"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-13"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-24"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="761">761</numbering><numbering type="pageLast" number="778">778</numbering></numberingGroup><correspondenceTo> Philip R. Cohen, MD, 805 Anderson Street, Bellaire, TX 77401‐2806 USA E‐mail: <email>mitehead@aol.com</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:IJD.IJD1891.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="2"></count><count type="tableTotal" number="7"></count><count type="formulaTotal" number="0"></count><count type="referenceTotal" number="266"></count><count type="wordTotal" number="5208"></count></countGroup><titleGroup><title type="main">Sweet's syndrome revisited: a review of disease concepts</title><title type="shortAuthors"><i>Cohen and Kurzrock</i></title><title type="short">Sweet"s syndrome revisited</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" corresponding="yes"><personName><givenNames>Philip R.</givenNames><familyName>Cohen</familyName><degrees>MD</degrees></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>Razelle</givenNames><familyName>Kurzrock</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="US"><unparsedAffiliation>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Sweet's syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by a constellation of symptoms and findings: fever, neutrophilia, erythematous and tender skin lesions that typically show an upper dermal infiltrate of mature neutrophils, and prompt improvement of both symptoms and lesions after the initiation of treatment with systemic corticosteroids. Hundreds of patients with this dermatosis have been reported. The manifestations of Sweet's syndrome in these individuals have not only confirmed those originally described by Dr Robert Douglas Sweet in 1964, but have also introduced new features that have expanded the clinical and pathologic concepts of this condition. The history, clinical characteristics, laboratory findings, associated diseases, pathology, and treatment options of Sweet's syndrome are reviewed. The evolving and new concepts of this dermatosis that are discussed include: (i) Sweet's syndrome occurring in the clinical setting of a disease‐related malignancy, or medication, or both; (ii) detection of additional sites of extracutaneous Sweet's syndrome manifestations; (iii) discovery of additional Sweet's syndrome‐associated diseases; (iv) variability of the composition and/or location of the cutaneous inflammatory infiltrate in Sweet's syndrome lesions; and (v) additional efficacious treatments for Sweet's syndrome.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Sweet's syndrome revisited: a review of disease concepts</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Sweet"s syndrome revisited</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Sweet's syndrome revisited: a review of disease concepts</title></titleInfo><name type="personal"><namePart type="given">Philip R.</namePart><namePart type="family">Cohen</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas</affiliation><affiliation>E-mail: mitehead@aol.com</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Razelle</namePart><namePart type="family">Kurzrock</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>From the University of Houston Health Center, Department of Dermatology, The University of Texas‐Houston Medical School, and Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Blackwell Publishing Ltd.</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2003-10</dateIssued><copyrightDate encoding="w3cdtf">2003</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">2</extent><extent unit="tables">7</extent><extent unit="references">266</extent><extent unit="words">5208</extent></physicalDescription><abstract lang="en">Sweet's syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by a constellation of symptoms and findings: fever, neutrophilia, erythematous and tender skin lesions that typically show an upper dermal infiltrate of mature neutrophils, and prompt improvement of both symptoms and lesions after the initiation of treatment with systemic corticosteroids. Hundreds of patients with this dermatosis have been reported. The manifestations of Sweet's syndrome in these individuals have not only confirmed those originally described by Dr Robert Douglas Sweet in 1964, but have also introduced new features that have expanded the clinical and pathologic concepts of this condition. The history, clinical characteristics, laboratory findings, associated diseases, pathology, and treatment options of Sweet's syndrome are reviewed. The evolving and new concepts of this dermatosis that are discussed include: (i) Sweet's syndrome occurring in the clinical setting of a disease‐related malignancy, or medication, or both; (ii) detection of additional sites of extracutaneous Sweet's syndrome manifestations; (iii) discovery of additional Sweet's syndrome‐associated diseases; (iv) variability of the composition and/or location of the cutaneous inflammatory infiltrate in Sweet's syndrome lesions; and (v) additional efficacious treatments for Sweet's syndrome.</abstract><relatedItem type="host"><titleInfo><title>International Journal of Dermatology</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0011-9059</identifier><identifier type="eISSN">1365-4632</identifier><identifier type="DOI">10.1111/(ISSN)1365-4632</identifier><identifier type="PublisherID">IJD</identifier><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><detail type="issue"><caption>no.</caption><number>10</number></detail><extent unit="pages"><start>761</start><end>778</end><total>18</total></extent></part></relatedItem><identifier type="istex">27456AA1A506415D425CC0EC1B7C644278247D02</identifier><identifier type="DOI">10.1046/j.1365-4362.2003.01891.x</identifier><identifier type="ArticleID">IJD1891</identifier><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Ltd.</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001198 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001198 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:27456AA1A506415D425CC0EC1B7C644278247D02
|texte= Sweet's syndrome revisited: a review of disease concepts
}}
| This area was generated with Dilib version V0.6.31. |  |